Jump to any asset
849 assets, updated daily
As of September 23, 2026, State Street Health Care Select Sector SPDR ETF (XLV) trades at $169.89. RSI at 44 is in neutral territory, and the price is above its 50-day average of $167.09.
State Street Health Care Select Sector SPDR ETF (XLV)
State Street Health Care Select Sector SPDR ETF NYSE
$169.89
0.8800 (0.52%)
At close: Sep 22, 4:00 PM EDT
AI Analyst Consensus
75 / 100
The State Street Health Care Select Sector SPDR ETF (XLV) offers broad exposure to U.S. health care companies, tracking the Health Care Select Sector Index. This ETF provides investors with a diversified mix of large-cap businesses across pharmaceuticals, biotechnology, health care equipment, providers, life sciences tools, and health care technology. Managed by State Street Investment Management, XLV employs a passive approach to mirror its benchmark, serving as a targeted tool for capturing the performance of the U.S. health care segment within the S&P 500. Its holdings typically include leading firms in drug development, medical products, managed care, and health services, making it a widely used instrument for sector-specific investment in the U.S. equity market.
XLV Price Analysis
Market Metrics
Open
$168.79
Day Range
$167.87 to $170.72
Prev Close
$169.01
Volume
7.04M
52-Week Range
$133.73 to $176.60
Market Cap
$28.32B
XLV Fund Facts
State Street Health Care Select Sector SPDR ETF is a sector-focused exchange-traded fund that provides broad exposure to U.S. health care companies. The fund is designed to track the Health Care Select Sector Index, giving investors access to a diversified mix of large-cap businesses across pharmaceuticals, biotechnology, health care equipment and supplies, health care providers and services, life sciences tools and services, and health care technology.
Issuer
State Street Investment Management
Category
Health
Inception
Dec 16, 1998
Expense ratio
0.08%
Net assets
$43.91B
NAV
$166.52
Distribution yield
1.49%
YTD return
11.08%
Turnover
2.00%
Sector weights
Healthcare
100.0%
Trailing returns vs category
| Period | XLV | Category |
|---|---|---|
| YTD | 11.08% | -2.39% |
| 1 month | 4.89% | 1.70% |
| 3 months | 14.50% | -3.03% |
| 1 year | 26.22% | 21.31% |
| 3 years | 10.40% | 6.58% |
| 5 years | 6.45% | 1.49% |
| 10 years | 10.73% | 8.56% |
Fund reference data as of Sep 23, 2026. Expense ratio and net assets are reported by the fund; returns are total returns and can differ from price change.
XLV Analysis
AI Technical Analysis
XLV is currently trading above its 50-day simple moving average of $167.09 and its 200-day simple moving average of $156.07. The 20-day exponential moving average is at $168.88, also below the current price. The Relative Strength Index (RSI) stands at 44.08, indicating a neutral momentum. The ETF's price is currently $169.89, suggesting it is consolidating near its recent highs with no strong overbought or oversold signals.
ProTips
- Consider XLV as a core defensive holding within a diversified portfolio.
- Monitor regulatory news impacting the pharmaceutical and healthcare services industries.
- Evaluate XLV's performance against its benchmark and category during periods of market stress.
- The low expense ratio makes XLV a cost-effective way to gain health care sector exposure.
Market Outlook
The outlook for XLV remains stable, supported by the defensive nature of the health care sector. Over the next 6-12 months, the ETF is expected to continue benefiting from consistent demand for health care services and products, even amidst broader market fluctuations. Its position above key moving averages suggests a potential for continued sideways movement or a gradual upward trend, contingent on sector-specific developments and overall market sentiment. Key factors to monitor include upcoming earnings reports from major health care companies, any significant legislative or regulatory changes impacting the sector, and the broader macroeconomic environment. A shift towards risk-on sentiment could see funds rotate out of defensive sectors, while increased market uncertainty could drive further inflows into health care ETFs like XLV.
Market Correlations
How this etf moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.43
Moderate correlation
Nasdaq 100 (QQQ)
+0.25
Weak correlation
Bitcoin (BTC)
-0.08
Weak correlation
Gold (XAU)
+0.10
Weak correlation
Check Custom Correlation
How does any other asset move with XLV? One year of daily closes, Pearson correlation.
Try
Key Statistics
| Net Assets (Market Cap) | 28.32B |
|---|---|
| Expense Ratio | 0.0900% |
| Yield | 1.50% |
| Day High | $170.72 |
| Day Low | $167.87 |
| 52 Week High | 176.60 |
| 52 Week Low | 133.73 |
The State Street Health Care Select Sector SPDR ETF (XLV) holds 100% of its assets in stocks, with a significant concentration in the health care sector. The fund's expense ratio is a low 0.08%, costing approximately $8.00 per $10,000 invested. With net assets totaling $43.91 billion, XLV is a substantial ETF. The health care sector is known for its defensive characteristics, often performing relatively well during economic downturns due to consistent demand for its products and services. This stability makes XLV a core holding for investors seeking to mitigate broader market volatility.
Earnings & Growth Analysis
Its underlying holdings represent companies within the health care sector. This sector typically demonstrates resilient earnings trends due to the non-discretionary nature of health services and pharmaceuticals. The broad diversification across sub-sectors like biotechnology, medical devices, and managed care helps to smooth out individual company earnings fluctuations. Investors look to the aggregate performance of these health care giants to gauge the sector's overall financial health and its contribution to the broader market.
Key Risks
The primary risk for XLV lies in potential regulatory changes impacting the health care industry, such as drug pricing reforms or changes to healthcare policy, which could affect the profitability of its top holdings. Concentration risk, though mitigated by diversification across sub-sectors, remains a factor as the fund tracks a specific sector index. Macroeconomic shifts, particularly those affecting consumer spending on healthcare services, could also influence the ETF's performance.
Technical Indicators
| RSI (14) | 44.08 |
|---|---|
| MACD | 0.14 |
| SMA 50 | 167.09 |
| SMA 200 | 156.07 |
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Neutral
Golden Cross in effect with the 50-day SMA ($167.09) above the 200-day SMA ($156.07), price action is firmly bullish above key moving averages.
XLV Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Long entry pick an entry style
Conservative
$166.49
2% below current price (Pullback entry)
Lower risk, wait for pullback
Aggressive
$169.89
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$161.50
MAX LOSS
-3.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (44.1) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$174.82
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$183.14
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$191.47
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
ETF Investment Disclaimer
This AI-generated analysis of XLV is for educational purposes only and does not constitute investment advice. ETFs are subject to market risk including possible loss of principal. Performance depends on the underlying index or assets tracked. Read the fund prospectus before investing. Past performance does not guarantee future results. Generated on September 23, 2026.Growth of $10,000
A $10,000 investment in XLV in September 2016 would be worth about $23,238 today, compared with about $35,806 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in XLV today could grow to about $21,628 by 2036 in the base case, with a bull case near $42,696 and a bear case around $10,956. Projections are statistical simulations, not guarantees.
XLV ETF Price Prediction: 2030
CleaRank's simulation projects a price near $231 for XLV by 2030 in the base case, from $170 today (1.4x over 4 years). The downside path ends near $150. These are outcomes of a Monte Carlo simulation run on XLV's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $148 | $184 | $228 |
| 2028 | $146 | $198 | $269 |
| 2029 | $148 | $214 | $311 |
| 2030 | $150 | $231 | $356 |
| 2031 | $154 | $250 | $404 |
| 2032 | $159 | $270 | $457 |
| 2033 | $165 | $292 | $515 |
| 2034 | $171 | $315 | $579 |
| 2035 | $178 | $340 | $648 |
| 2036 | $186 | $367 | $725 |
Method: 10,000 simulated price paths using XLV's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
Frequently Asked Questions
What is the expense ratio for the State Street Health Care Select Sector SPDR ETF (XLV)?
The expense ratio for XLV is 0.08%, which translates to approximately $8.00 per $10,000 invested annually. This low cost is a key feature for long-term investors in this sector-tracking ETF.
What sectors does the XLV ETF concentrate its holdings in?
The XLV ETF is highly concentrated in the health care sector, holding 100% of its assets in stocks within this industry. This includes pharmaceuticals, biotechnology, health care equipment, and health care providers and services.
What is the distribution yield for the XLV ETF?
The XLV ETF has a distribution yield of approximately 1.50%. This yield reflects the income generated from the underlying health care companies and distributed to shareholders.
How has XLV performed against its category over the past year?
Over the past year, XLV has returned 26.22%, outperforming its category return of 21.31%. This indicates strong performance relative to its peers in the health care sector.
What is the price prediction for XLV ETF in 2030?
Based on a Monte Carlo simulation, the base case price projection for XLV in 2030 is $231.30. The simulation also indicates a downside price of $150.44 and an upside price of $355.62. These figures represent statistical outcomes and are not price targets or guarantees.
What are the key risks associated with investing in the XLV ETF?
Key risks include potential regulatory changes affecting the health care industry, such as drug pricing reforms, and concentration risk within the health care sector. Macroeconomic shifts impacting healthcare spending also pose a risk.
How does the State Street Health Care Select Sector SPDR ETF (XLV) compare to its benchmark index?
XLV aims to track the Health Care Select Sector Index. Its performance, such as the 11.08% year-to-date return compared to the category's -2.39%, suggests it closely mirrors the index's movements and provides effective sector exposure.
What is the current technical momentum of the XLV ETF?
The current technical momentum for XLV is neutral, with an RSI at 44.1. The ETF is trading above its key moving averages (50-day SMA at $167.09, 200-day SMA at $156.07), indicating stability rather than strong directional trend.